We are live on ! Find out more

52 hedge funds and large institutions have $14.2M invested in PAVmed in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

560% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 5

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

117% more funds holding

Funds holding: 2452 (+28)

111% more capital invested

Capital invested by funds: $6.73M → $14.2M (+$7.46M)

0.01% more ownership

Funds ownership: 0.02%0.03% (+0.01%)

Holders
52
Holders Change
+28
Holders Change %
+116.67%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
10
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q2 2020 in Review

52 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2020, worth a combined $14.2M — up 111% from $6.73M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new PAVM positions and 5 closed out — a net gain of 28 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $3.7M. The largest seller was Belpointe Asset Management, cutting an estimated $716K.

  • 52 institutional investors held PAVmed (PAVM) as of Q2 2020, up from 24 in Q1 2020.
  • Funds reported $14.2M of PAVmed stock for Q2 2020, up 111% quarter-over-quarter.
  • 33 funds opened new PAVmed positions in Q2 2020 and 5 closed out, a net change of +28 holders.
  • The largest PAVmed buyer in Q2 2020 was BlackRock, an estimated $3.7M added.
  • The largest PAVmed seller in Q2 2020 was Belpointe Asset Management, an estimated $716K sold.

Based on aggregated 13F filings for Q2 2020.